Pharmaceutical Preparations · DE · CIK 1847367
Develop targeted therapies for immune-mediated diseases using precision data analytics and biological insights
Comparable business profile · signals at a glance
In the 90 days to Jan 9, 2026: 6 insiders bought $51.0M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 9, 2026 | Akkaraju SrinivasDirector | Buy | 588,235 | $17.00 | $10.0M |
| Jan 8, 2026 | Foresite Labs Fund I, L.P.TenPercentOwner | Buy | 294,117 | $17.00 | $5.0M |
| Jan 8, 2026 | Tananbaum James B.Director,TenPercentOwner | Buy | 294,117 | $17.00 | $5.0M |
| Jan 8, 2026 | Foresite Labs, LlcTenPercentOwner | Buy | 294,117 | $17.00 | $5.0M |
| Jan 8, 2026 | Foresite Labs, LlcTenPercentOwner | Buy | 117,647 | $17.00 | $2.0M |
| Jan 8, 2026 | Foresite Labs Fund I, L.P.TenPercentOwner | Buy | 117,647 | $17.00 | $2.0M |
| Jan 8, 2026 | Tananbaum James B.Director,TenPercentOwner | Buy | 117,647 | $17.00 | $2.0M |
| Dec 5, 2025 | Akkaraju SrinivasDirector | Buy | 70,028 | $10.01 | $701K |
| Dec 5, 2025 | Akkaraju SrinivasDirector | Buy | 64,969 | $8.95 | $581K |
| Dec 5, 2025 | Akkaraju SrinivasDirector | Buy | 51,380 | $10.73 | $551K |
| Dec 4, 2025 | Akkaraju SrinivasDirector | Buy | 66,027 | $8.18 | $540K |
| Dec 3, 2025 | Akkaraju SrinivasDirector | Buy | 100,000 | $7.75 | $775K |
| Dec 2, 2025 | Akkaraju SrinivasDirector | Buy | 96,000 | $7.55 | $725K |
| Dec 1, 2025 | Akkaraju SrinivasDirector | Buy | 86,350 | $7.46 | $644K |
| Nov 28, 2025 | Akkaraju SrinivasDirector | Buy | 38,702 | $7.64 | $296K |
| Nov 26, 2025 | Akkaraju SrinivasDirector | Buy | 48,537 | $7.64 | $371K |
| Nov 21, 2025 | Foresite Labs Affiliates 2021, LlcTenPercentOwner | Buy | 72,212 | $7.38 | $533K |
| Nov 21, 2025 | Foresite Labs Fund I, L.P.TenPercentOwner | Buy | 72,212 | $7.38 | $533K |
| Nov 21, 2025 | Tananbaum James B.Director,TenPercentOwner | Buy | 72,212 | $7.38 | $533K |
| Nov 20, 2025 | Akkaraju SrinivasDirector | Buy | 125,743 | $7.20 | $905K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.